Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideyuki Arita

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Radiation Oncology (London, England)|July 26, 2024
Association of increasing gross tumor volume dose with tumor volume reduction and local control in fractionated stereotactic radiosurgery for unresected brain metastasesNaoyuki Kanayama, Toshiki Ikawa, Koji Takano, et al.
Neurologia Medico-Chirurgica|January 6, 2011
Posttransplant lymphoproliferative disorders of the central nervous system after kidney transplantation: single center experience over 40 years. Two case reportsHideyuki Arita, Shuichi Izumoto, Manabu Kinoshita, et al.
Radiation Oncology (London, England)|May 10, 2023
Linear accelerator-based stereotactic radiotherapy for brain metastases, including multiple and large lesions, carries a low incidence of acute toxicities: a retrospective analysisToshiki Ikawa, Naoyuki Kanayama, Hideyuki Arita, et al.
Brain Tumor Pathology|December 11, 2017
Enchondromatosis-associated oligodendroglioma: case report and literature reviewTakamune Achiha, Hideyuki Arita, Naoki Kagawa, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomasHideyuki Arita, Yoshitaka Narita, Hirokazu Takami, et al.
Brain Tumor Pathology|April 22, 2014
Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomasHideyuki Arita, Yoshitaka Narita, Yuko Matsushita, et al.
Pituitary|July 4, 2012
Prevalence of cerebral aneurysm in patients with acromegalySatoru Oshino, Akio Nishino, Tsuyoshi Suzuki, et al.
Journal of Radiation Research|August 18, 2024
Multifraction stereotactic radiotherapy utilizing inhomogeneous dose distribution for brainstem metastases: a single-center retrospective analysisToshiki Ikawa, Naoyuki Kanayama, Hideyuki Arita, et al.
The Journal of Clinical Endocrinology and Metabolism|May 10, 2012
Biological characteristics of growth hormone-producing pituitary adenomas are different according to responsiveness to thyrotropin-releasing hormoneHideyuki Arita, Manabu Kinoshita, Satoru Oshino, et al.
Brain Tumor Pathology|February 16, 2017
Erratum to: Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomasHideyuki Arita, Yoshitaka Narita, Yuko Matsushita, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Radiation Oncology (London, England)|July 26, 2024
Association of increasing gross tumor volume dose with tumor volume reduction and local control in fractionated stereotactic radiosurgery for unresected brain metastasesNaoyuki Kanayama, Toshiki Ikawa, Koji Takano, et al.
Neurologia Medico-Chirurgica|January 6, 2011
Posttransplant lymphoproliferative disorders of the central nervous system after kidney transplantation: single center experience over 40 years. Two case reportsHideyuki Arita, Shuichi Izumoto, Manabu Kinoshita, et al.
Radiation Oncology (London, England)|May 10, 2023
Linear accelerator-based stereotactic radiotherapy for brain metastases, including multiple and large lesions, carries a low incidence of acute toxicities: a retrospective analysisToshiki Ikawa, Naoyuki Kanayama, Hideyuki Arita, et al.
Brain Tumor Pathology|December 11, 2017
Enchondromatosis-associated oligodendroglioma: case report and literature reviewTakamune Achiha, Hideyuki Arita, Naoki Kagawa, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomasHideyuki Arita, Yoshitaka Narita, Hirokazu Takami, et al.
Brain Tumor Pathology|April 22, 2014
Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomasHideyuki Arita, Yoshitaka Narita, Yuko Matsushita, et al.
Pituitary|July 4, 2012
Prevalence of cerebral aneurysm in patients with acromegalySatoru Oshino, Akio Nishino, Tsuyoshi Suzuki, et al.
Journal of Radiation Research|August 18, 2024
Multifraction stereotactic radiotherapy utilizing inhomogeneous dose distribution for brainstem metastases: a single-center retrospective analysisToshiki Ikawa, Naoyuki Kanayama, Hideyuki Arita, et al.
The Journal of Clinical Endocrinology and Metabolism|May 10, 2012
Biological characteristics of growth hormone-producing pituitary adenomas are different according to responsiveness to thyrotropin-releasing hormoneHideyuki Arita, Manabu Kinoshita, Satoru Oshino, et al.
Brain Tumor Pathology|February 16, 2017
Erratum to: Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomasHideyuki Arita, Yoshitaka Narita, Yuko Matsushita, et al.
Pageof 8